| 1 |
Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation [J]. Immunol Rev, 2017, 278(1): 162-172.
|
| 2 |
Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease [J]. J Allergy Clin Immunol, 2013, 131(3): 636-645.
|
| 3 |
Bartemes KR, Kephart GM, Fox SJ, et al. Enhanced innate type 2 immune response in peripheral blood from patients with asthma [J]. J Allergy Clin Immunol, 2014, 134(3): 671-678.
|
| 4 |
Al-Ramli W, Préfontaine D, Chouiali F, et al. T(h)17-associated cytokines (IL-17A and IL-17F) in severe asthma [J]. J Allergy Clin Immunol, 2009, 123(5): 1185-1187.
|
| 5 |
Rouvier E, Luciani MF, Mattei MG, et al. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene [J]. J Immunol, 1993, 150(12): 5445-5456.
|
| 6 |
Yao Z, Fanslow WC, Seldin MF, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor [J]. Immunity, 1995, 3(6): 811-821.
|
| 7 |
Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines [J]. J Exp Med, 1996, 183(6): 2593-2603.
|
| 8 |
Lee J, Ho WH, Maruoka M, et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1 [J]. J Biol Chem, 2001, 276(2): 1660-1664.
|
| 9 |
Hirota K, Duarte JH, Veldhoen M, et al. Fate mapping of IL-17-producing T cells in inflammatory responses [J]. Nature Immnology, 2011, 12(3): 255-263.
|
| 10 |
Veldhoen M. Interleukin-17 is a chief orchestrator of immunity [J]. Nat Immunol, 2017, 18(6): 612-621.
|
| 11 |
Schwandner R, Yamaguchi K, Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF) 6 in interleukin-17 signal transduction [J]. J Exp Med, 2000, 191(7): 1233-1240.
|
| 12 |
Qian Y, Liu C, Hartupee J, et al. The adaptor Act1 is required for interleukin 17 - dependent signaling associated with autoimmune and inflammatory disease [J]. Nat Immunol, 2007, 8(3): 247-256.
|
| 13 |
Hartupee J, Liu C, Novotny M, et al. IL-17 enhances chemokine gene expression through mRNA stabilization [J]. J Immunol, 2007, 179(6): 4135-4141.
|
| 14 |
Zepp JA, Liu C, Qian W, et al. Cutting edge: TNF receptor - associated factor 4 restricts IL-17-mediated pathology and signaling processes [J]. J Immunol, 2012, 189(1): 33-37.
|
| 15 |
Zhu S, Pan W, Shi P, et al. Modulation of experimental autoimmune encephalomyelitis through TRAF3 - mediated suppression of interleukin 17 receptor signaling [J]. J Exp Med, 2010, 207(12): 2647-2662.
|
| 16 |
Infante-Duarte C, Horton HF, Byrne MC, et al. Microbial lipopeptides induce the production of IL-17 in Th cells [J]. J Immunol, 2000, 165(11): 6107-6115.
|
| 17 |
Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation [J]. J Exp Med, 2005, 201(2): 233-240.
|
| 18 |
Sutton CE, Lalor SJ, Sweeney CM, et al. Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity [J]. Immunity, 2009, 31(2): 331-341.
|
| 19 |
Martin B, Hirota K, Cua DJ, et al. Interleukin-17-producing γδ T cells selectively expand in response to pathogen products and environmental signals [J]. Immunity, 2009, 31(2): 321-330.
|
| 20 |
Takatori H, Kanno Y, Watford WT, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22 [J]. J Exp Med, 2009, 206(1): 35-41.
|
| 21 |
Spits H, Artis D, Colonna M, et al. Innate lymphoid cells-a proposal for uniform nomenclature [J]. Nat Rev Immunol, 2013, 13(2): 145-149.
|
| 22 |
Rachitskaya AV, Hansen AM, Horai R, et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion [J]. J. Immunol, 2008, 180(8): 5167-5171.
|
| 23 |
Reynolds JM, Angkasekwinai P, Dong C. IL-17 family member cytokines: regulation, and function in innate immunity [J]. Cytokine Growth Factor Rev, 2010, 21(6): 413-423.
|
| 24 |
Moran EM, Mullan R, McCormick J, et al. Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies [J]. Arthritis Res Ther, 2009, 11(4): R113.
|
| 25 |
Miossec P. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy [J]. Arthritis Rheum, 2003, 48(3): 594-601.
|
| 26 |
Van Hamburg JP, Asmawidjaja PS, Davelaar N, et al. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin -17A production [J]. Arthritis Rheum, 2011, 63(1): 73-83.
|
| 27 |
Andoh A, Ogawa A, Bamba S, et al. Interaction between interleukin-17-producing CD4+ T cells and colonic subepithelial myofibroblasts: what are they doing in mucosal inflammation? [J]. J Gastroenterol, 2007, 42 Suppl 17: 29-33.
|
| 28 |
Huppert J, Closhen D, Croxford A, et al. Cellular mechanisms of IL-17-induced blood-brain barrier disruption [J]. FASEB J, 2010, 24(4): 1023-1034.
|
| 29 |
Roussel L, Houle F, Chan C, et al. IL-17 promotes p38 MAPK - dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation [J]. J Immunol, 2010, 184(8): 4531-4537.
|
| 30 |
Green RH, Brightling CE, Woltmann G, et al. Analysis of induced sputum in adults with asthma:identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids [J]. Thorax, 2002, 57(10): 875-879.
|
| 31 |
McKinley L, Alcorn JF, Peterson A, et al. Th17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice [J]. J Immunol, 2008, 181(6): 4089-4097.
|
| 32 |
Chen Y, Thai P, Zhao YH, et al. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop [J]. J Biol Chem, 2003, 278(19): 17036-17043.
|
| 33 |
Manni ML, Robinson KM, Alcorn JF. A tale of two cytokines: IL-17 and IL-22 in asthma and infection [J]. Expert Rev Respir Med, 2014, 8(1): 25-42.
|
| 34 |
Alcorn JF, Crowe CR, Kolls JK. Th17 cells in asthma and COPD [J]. Annu Rev Physiol, 2010, 72: 495-516.
|
| 35 |
Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8 [J]. Chest, 2001, 119(5): 1329-1336.
|
| 36 |
Wenzel SE, Balzar S, Cundall M, et al. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair [J]. J Allergy Clin Immunol, 2003, 111(6): 1345-1352.
|
| 37 |
Agache I, Ciobanu C, Agache C, et al. Increased serum IL-17 is an independent risk factor for severe asthma [J]. Respir Med, 2010, 104(8): 1131-1137.
|
| 38 |
赵生涛. IL-17在中性粒细胞性哮喘中的作用及其调控气道炎症表型的机制研究[D]. 重庆:第三军医大学, 2017: 60-62.
|
| 39 |
Bush A, Saglani S. Management of severe asthma in children [J]. Lancet, 2010, 376(9743): 814-825.
|
| 40 |
Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma [J]. Am J Respir Crit Care Med, 2009, 180(5): 388-395.
|
| 41 |
Bergeron C, Boulet LP. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation [J]. Chest, 2006, 129(4): 1068-1087.
|
| 42 |
Bellini A, Marini MA, Bianchetti L, et al. Interleukin(IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients [J]. Mucosal Immunol, 2012, 5(2): 140-149.
|
| 43 |
Pain M, Bermudez O, Lacoste P, et al. Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype [J]. Eur Respir Rev, 2014, 23(131): 118-130.
|
| 44 |
Chang Y, Al-Alwan L, Risse P-A, et al. Th17-associated cytokines promote human airway smooth muscle cell proliferation [J]. FASEB J, 2012, 26(12): 5152-5160.
|
| 45 |
Dragon S, Rahman MS, Yang J, et al. IL-17 enhances IL-1 beta - mediated CXCL-8 release from human airway smooth muscle cells [J]. Am J Physiol Lung Cell Mol Physiol, 2007, 292(4): L1023-L1029.
|
| 46 |
Loirand G, Sauzeau V, Pacaud P. Small G Proteins in the Cardiovascular System: Physiological and Pathological Aspects [J]. Physiol Rev, 2013, 93(4): 1659-1720.
|
| 47 |
Jin J. JAMA PATIENT PAGE. Asthma Attacks [J]. JAMA, 2016, 315(8): 832.
|